InvestorsHub Logo
Followers 274
Posts 32167
Boards Moderated 0
Alias Born 02/14/2014

Re: TheTradingNinja post# 782

Thursday, 10/02/2014 7:14:50 AM

Thursday, October 02, 2014 7:14:50 AM

Post# of 1397
Couple additional items to your fine DD work. I am not great at putting pictures so I will just provide links

The executive team, is legit and reads like a NASDAQ biotech company, not some OTC stinky pinky

http://ir.viveve.com/management-team

CFO Scott Durbin

Scott joined Viveve as Chief Financial Officer in January 2013. His 20 year career in corporate finance and strategy for the life science industry brings a wealth of finance experience to our organization. Prior to joining Viveve, he was Chief Financial Officer of Aastrom Biosciences, a publicly traded, cardiovascular cell therapy company. Before Aastrom, he spent six years as Chief Operating and Financial Officer for Prescient Medical, a privately held company that developed diagnostic imaging catheters and coronary stents designed to reduce deaths from heart attacks. Prior to Prescient, he spent several years as a financial consultant for two publicly traded biotech companies, Scios, Inc. – a Johnson & Johnson company and Alteon, Inc. He began his career in corporate finance as an investment banker in the Healthcare and M&A groups at Lehman Brothers Inc., where he focused on mergers and acquisitions and financings for the life science industry. At Lehman, he successfully executed over $5 billion in transactions for medical device and biotech companies. He began his career as a Director of Neurophysiology for Biotronic, Inc. Scott received a B.S. from the University of Michigan and an M.P.H. in Health Management with Honors from the Yale University School of Medicine and School of Management.

While Scott was at Aastrom it was a $25/share NASDAQ biotech company, after he left it took a nose dive, but he does have big time experience and a much more detailed track record than most OTC start ups.

Another thing was the company has been around for a number of years, with patented technology sold overseas. they are now ready to be granted 510K indication in the US which makes perfect sense why they would go public now on a US stock exchange.

Further, their auditing firm Burr Pilger Mayer

http://ir.viveve.com/ir-contacts

Is a big time accounting firm, they may not be the big four but they are PCAOB accredited and very legit

http://www.bpmcpa.com/

They are a very large firm and once again shows that this company is not messing around and does not intend to be an OTC share printing scam. Audit firms like this do not get into bed with crooks as it tarnishes their image in the industry, and when you are trying to play with the big boys image is everything

More and more this is looking like a great place to put your $$$ for a couple months to see where things are headed.